Registration open: EURETINA 2021 virtual programme covers 4 days, 5 channels

Article

Programming includes 16 EURETINA sessions; 22 symposia; 44 instructional courses; 85 hours of content, and more than 300 speakers.

Registration open: EURETINA 2021 virtual programme provides 4 days, 5 channels

Registration is open now for this year’s EURETINA 2021 virtual programme, scheduled for 9 to 12 September.

Early fees are available until Tuesday 31 August. Delegates may register for the virtual congress until 12:30 pm Central European Summer Time (CEST) on Sunday 12 September.

Prof Frank Holz

Prof. Holz

“This year marks the society’s 21st annual congress and our second in virtual format,” said Prof Frank G. Holz, EURETINA President. “Thanks to the hard work of the board and programme committee, we anticipate a dynamic meeting, which, this year, will extend to 4 days of content across 5 parallel channels.”

Programming includes 16 EURETINA sessions; 22 symposia; 44 instructional courses; 85 hours of content, and more than 300 speakers.

Featured lectures include:

  • Thursday 9 September: EURETINA Lecture 2021: “Choriocapillaris in AMD: New insights into pathophysiology” by SriniVas Sadda, MD, Los Angeles, California, USA
  • Saturday 11 September: Gisbert Richard Lecture 2021: “Visual acuity following retinal detachment surgery” by Prof. Heinrich Heimann, MD, Liverpool, UK
  • Saturday 11 September: Kreissig Award Lecture: “Neuroprotective strategy for non-arteritic central retinal artery occlusion” by Ogugua Okonkwo, MD, FRCS (Edin), FASRS, Nigeria
  • Saturday 11 September: Ophthalmologica Award Lecture: “Serous business: Dissecting the broad spectrum of diseases with subretinal fluid in the macula” by Prof. dr. Camiel Boon, MD, The Netherlands

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.